Tianeptine sodium (Stablon, Coaxil, Tianeurax, Tatinol, Salymbra), the sodium salt of tianeptine and an atypical antidepressant, is a potent and selective serotonin reuptake enhancer (SSRE) used primarily for the treatment of major depressive disorders.

Quetiapine Fumarate (Seroquel XR; IC-204,636; ICI204,636; ICI-204636), the fumarate salt of Quetiapine, is an atypical antipsychotic drug used for the treatment of schizophrenia, bipolar I mania, bipolar II depression, bipolar I depression.

Methotrimeprazine (Levomepromazine) is a potent phenothiazine-based neuroleptic drug.

LY310762 (LY-310762; LY 310762) is a potent 5-HT1D serotonin receptor antagonist with important biological activity.

Dapoxetine HCl (formerly known as LY210448; LY-210448; trade name Priligy), an antidepressant, is a novel, potent, short-acting and selective serotonin reuptake inhibitor (SSRI) that has alto been used for the treatment of premature ejaculation.

Citalopram Hydrobromide (Lu-10-171) is a potent and FDA approved antidepressant drug of the selective serotonin reuptake inhibitor (SSRI) class.

Tropisetron HCl (Navoban; ICS-205930; ICS 205-930), the hydrochloride salt of Tropisetron which is an anti-emetic drug, is a novel, potent and selective 5-HT3 receptor antagonist and α7-nicotinic receptor agonist that has been approved for the treatment of chemotherapy-induced nausea and vomiting.

Azasetron HCl (formerly Y 25130 HCl; Y-25130; Y25130), an approved antiemetic drug, is a potent and selective antagonist of 5-HT3 receptor with an IC50 of 0.33 nM.

Volinanserin (MDL-100907; M-100907) is a highly selective 5-HT2A receptor antagonist with antipsychotic activity and thus has the potential for treatment of schizophrenia.

Tandospirone citrate (SM-3997) is a novel, highly potent and selective 5-HT1A receptor partial agonist with Ki of 27 nM, and exhibits selectivity over SR-2, SR-1C, α1, α2, D1 and D2 receptors (Kis ranging from 1300-41000 nM).